Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2002

View Archived Issues

Landmark LIPS trial demonstrates significant reduction in risk of cardiac events on fluvastatin

Rationally designed anticancer drugs targeting key enzymes as a new approach to breast cancer

OCTAVE and OVERTURE results for Vanlev disclosed by BMS

HSV-1 glycoprotein D vaccine affords high and sustained protective immunity in animal models

Pharmacokinetics, oral bioavailability of potential new agent for HCMV

Xoma summarizes highlights of 2001

Anti-TNF antibodies prepared by scientists at Centocor

Vaccine for West Nile virus highly effective in mice, slated for clinical trials this year

Centocor patents series of anti-IL-12 antibodies

Compounds for cancer gene therapy reported by Fujisawa

Investigators at Shiseido identify new MMP inhibitors

Inhibitors of IL-1beta production synthesized at Kowa

Research at Ono leads to the design of new PDE4 inhibitors

Aventis discloses compounds active against telomerase

NeoTherapeutics presents summary of 2001 results

American College of Cardiology meeting highlights available to Daily Essentials readers

FDA advisory committee votes against recommending approval of Picovir

Canadian IND approval for buccal morphine in the treatment of pain

Phase III open-label study of Alprox-TD begins in male erectile dysfunction

Multiple phase III trials initiated for NBI-34060 in insomnia

Irofulven tested in cancer patients in combination with cisplatin

Antares Pharma and MacroMed team up to develop depot delivery systems

Alliance and Inhale expand PulmoSpheres agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...